论文部分内容阅读
目的:探讨舒利迭治疗支气管哮喘的疗效。方法:将167例支气管哮喘患者分为两组,对照组83例给予常规治疗,治疗组84例于常规治疗基础上给予舒利迭治疗。结果:治疗组总有效率为98.81%,不良反应发生率为9.52%,对照组总有效率为78.31%,不良反应发生率为8.43%,两组总有效率差异有统计学意义(P<0.05),不良反应发生率差异无统计学意义(P>0.05)。结论:对支气管哮喘患者给予舒利迭治疗,可取得较好的疗效,总有效率高,不良反应少。
Objective: To investigate the effect of seretide on bronchial asthma. Methods: 167 patients with bronchial asthma were divided into two groups, the control group of 83 patients given conventional treatment, the treatment group of 84 patients on the basis of conventional treatment given seretide treatment. Results: The total effective rate was 98.81%, the adverse reaction rate was 9.52% in the treatment group, the total effective rate in the control group was 78.31%, the adverse reaction rate was 8.43%, the total effective rate was statistically significant (P <0.05 ), No significant difference in the incidence of adverse reactions (P> 0.05). Conclusion: Patients with bronchial asthma given seretide treatment can achieve better efficacy, the total effective rate, fewer adverse reactions.